GGrantIndex
← Search

In Vivo Translational Imaging Shared Resource

$1P30FY2023CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

IN VIVO TRANSLATIONAL IMAGING SHARED RESOURCE (IVTISR) PROJECT SUMMARY/ABSTRACT The In Vivo Translational Imaging Shared Resource (IVTISR) was developed to provide UC Davis Comprehensive Cancer Center (UCDCCC) members outstanding resources in the rapidly evolving field of non- invasive imaging technologies, addressing the strong demand for these technologies by UCDCCC members. In vivo imaging in animal models of human disease and in humans is an integral part of addressing cancer outcomes and in assessing and addressing diagnostic and therapeutic approaches. The IVTISR provides in vivo imaging equipment, and dedicated imaging protocols and expertise that are critical to the advancement of understanding basic mechanisms of cancer as well as the translation of new oncologic diagnostic and therapeutic tools to the clinic. Guidance is also provided on experimental design involving in vivo imaging, Institutional Animal Care and Use Committee (IACUC) and Institutional Review Board (IRB) protocols, imaging data analysis and interpretation, as well as on manuscript and grant preparation/budgeting. The IVTISR consists of three units; the Center for Molecular and Genomic Imaging (CMGI) that supports small animal in vivo imaging, biospecimen imaging and preclinical radiochemistry, the Center for Imaging Science (CIS) that supports imaging studies in large animals, and the EXPLORER Molecular Imaging Center (EMIC), that supports human positron emission tomography/computed tomography (PET/CT) studies. Therefore, as a whole this shared resource uniquely supports imaging studies from rodent models of cancer to larger animals such as cats and dogs with spontaneous cancers to humans with oncologic conditions. Oversight and management of the IVTISR is provided by the Director, Abhijit Chaudhari, MS, PhD, the Director of the CMGI with over 15 years of experience in animal and human cancer imaging with various imaging modalities, quantitative imaging science, imaging biomarker design and validation and medical image processing; the co- Director, Allison Zwingenberger, DVM, MAS, a board-certified veterinary radiologist with extensive experience in cancer imaging using CT, MRI, and ultrasound in companion animal models of cancer; and the co-Director, Lorenzo Nardo, MD, PhD, radiologist with extensive training in MRI, CT, and molecular imaging in the diagnosis, follow up and treatment of cancer. The Specific Aims for the IVTISR are to: 1) Provide UCDCCC members with access to a broad range of in vivo imaging technologies, including molecular imaging technologies, such as PET, single photon emission computed tomography (SPECT) and optical imaging, quantitative physiologic imaging with ultrasound, and anatomic imaging with CT and magnetic resonance imaging (MRI). 2) Provide expertise in planning, executing and analyzing in vivo imaging studies. 3) Support imaging studies in rodent models (primarily at the CMGI), in larger animals with spontaneously arising cancers (primarily at the CIS), and humans (primarily at the EMIC). 4) Continue to seek state-of-the-art in vivo imaging technologies that will enhance UCDCCC members' research endeavors.

View original record on NIH RePORTER →
In Vivo Translational Imaging Shared Resource · GrantIndex